Safety and Efficacy of Myeloablative Conditioning Autologous Stem Cell Transplantation, Targeted Immunotherapy, and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Children, Adolescents, and Young Adults with Relapsed/Refractory Mature B-Cell Non Hodgkin Lymphoma

Authors

Aliza Gardenswartz, New York Medical College
Brinda Mehta, New York Medical College
Nader K. El-Mallawany, New York Medical CollegeFollow
Carmella van der Ven, New York Medical College
Jessica Hochberg, New York Medical CollegeFollow
Allyson Flower, New York Medical CollegeFollow
Erin Morris
Lauren Harrison, New York Medical CollegeFollow
Jaclyn Basso
Perry Gerard, New York Medical College
Janet Ayello, New York Medical CollegeFollow
Lee Ann Baxter-Lowe
Mitchell S. Cairo, New York Medical CollegeFollow

Document Type

Abstract

Publication Date

9-2018

Journal Title

British Journal of Haematology

Department

Pediatrics

Second Department

Radiology

Third Department

Health Behavior and Community Health

Recommended Citation

Gardenswartz, A., Mehta, B., El-Mallawany, N. K., van der Ven, C., Hochberg, J., Flower, A., Morris, E., Harrison, L., Basso, J., Gerard, P., Ayello, J., Baxter-Lowe, L., & Cairo, M. S. (2018). Safety and Efficacy of Myeloablative Conditioning Autologous Stem Cell Transplantation, Targeted Immunotherapy, and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Children, Adolescents, and Young Adults with Relapsed/Refractory Mature B-Cell Non Hodgkin Lymphoma. British Journal of Haematology, 182 (Suppl. 1), 23. https://doi.org/10.1016/j.bbmt.2018.12.832